Limor Rubin Aviv Talmon Yaarit Ribak Asa Kessler Yossi Martin Tal Keidar Haran Oded Shamriz Irit Adini Yuval Tal
10.3389/fimmu.2023.1134178
Front Immunol
2023 Apr 28;14:1134178.
il-5 antibody biotherapeutic agent drug reaction with eosinophilia and systemic symptoms (dress) interleukin (il) monoclonal antibodies (mabs)
CC BY
https://pubmed.ncbi.nlm.nih.gov/37187735/
Drug Hypersensitivity Syndrome / diagnosis Drug Hypersensitivity Syndrome / drug therapy Drug Hypersensitivity Syndrome / etiology Eosinophilia / complications Eosinophilia / drug therapy Interleukin-5 / metabolism
Drug Hypersensitivity Syndrome / diagnosis Drug Hypersensitivity Syndrome / drug therapy Drug Hypersensitivity Syndrome / etiology Eosinophilia / complications Eosinophilia / drug therapy Interleukin-5 / metabolism Review Anti-Bacterial Agents / therapeutic use COVID-19 / complications Female Humans Male Middle Aged Prospective Studies Anti-Bacterial Agents Interleukin-5
PMC10175640
37187735
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome
2023